SUSAN JUDGE BURNS: Open Payments
NPI 1073556981 · NORWOOD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,373 in 104 payments from 18 companies in 2025. Trend: 2023 $1,976 · 2024 $2,017 · 2025 $2,373
Food & beverage: $2,373
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $429 |
| Novo Nordisk Inc | 12 | $402 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $307 |
| Lilly USA, LLC | 15 | $294 |
| PFIZER INC. | 11 | $226 |
| ABBVIE INC. | 10 | $143 |
| Astellas Pharma US Inc | 4 | $119 |
| Exact Sciences Corporation | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| Lundbeck LLC | 2 | $64 |
Products named: JARDIANCE, FARXIGA, Wegovy, REXULTI, Veozah, QULIPTA, NURTEC ODT, BREZTRI.
Industry payments across MA — which companies pay providers there.
